Kakehashi

Active#13 in Japan

Estimated valuation · Pharmacy software · Japan

Provides cloud electronic medication records, patient follow-up and inventory tools for community pharmacies, helping pharmacists manage prescriptions and patient care across Japan.

Digital health›pharmacy software kakehashi.life

Founded2016

HQTokyo

Last roundSeries D · Jun 2025

Country of originJapanListed in the Japan ranking

Where would you invest?JapanJurisdiction as cited by the ranking

Estimated valuation

AI · Japan ranking

≈ USD 440MUSD 350–550M · Hundreds of M$

Hundreds of k$

Millions $

Tens of M$

Hundreds of M$

Unicorn

Decacorn

Hectocorn

Published valuation: USD 442.9M · Jul 2025
AI adjustment: None

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Uback rankings

How the AI ranks →

Ranking	Tier	Rank	Edition	Next update
Japan · all sectors	Top 50	#13	Edition 0 · October 2026	10 Jan 2027

Rank historyOct 2026 · #13First edition: no movements yet.

Funding history

Date	Round	Amount	Type	Investors
Jun 2025	Series D	amount undisclosed	—	Goldman Sachs, JIC Venture Growth Investments, JP Investment, MUFG Capital, DNX Ventures

Post-money about JPY 65.1bn (estimate incl. potential shares).

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Kakehashi as a PDF. It must answer at least one of these four questions, and stick to them:

AI valuation: $440MUndervalued or overvalued?

Versus competitorsHow does it compare?

Who should acquire itStrategic buyers, and why

Who should it acquireAcquisition targets, and why

Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Invest

Back Kakehashi whether or not it has agreed: your intention joins the pool on Kakehashi, passed to the Fundraising Desk of its country once it reaches critical mass. Backing on Uback (pronounced “you back”) means declaring an Interest (free) or an Intention (coming soon). Backing does not mean that this company is raising funds or that a shareholder is selling shares, and it is not a commitment to invest. Any deal, through a funding round or a sale by an existing shareholder, is handled by a partner desk: the Fundraising Desk of the country for a round, the Secondary Sales Desk assigned to the company for a sale.

Back Kakehashi Or back digital health in Japan

Pool on KakehashiBelow threshold

BackersBelow threshold

Paid intention · valid for life · movable until you sign with a partner desk. If the company does not follow up, Uback invites its Backers to move their intentions to a competitor or a similar company. Investing in non-listed companies carries a risk of losing all the capital invested.

Do you run Kakehashi?

Claim this profile to correct data, add your logo and description, or tell Uback about an upcoming round.

Claim this profile Report an upcoming round → Report an error →

Are you a shareholder?

Considering selling some of your shares? Tell Uback privately. Nothing is published without your consent, and never a price or a volume.

Tell Uback privately

What the AI reads

Read by the AI at the next edition.

Comparable companies in Japan

Full Japan ranking →

Linc'well#16Digital health › digital clinicsHundreds of M$CureApp#22Digital health › digital therapeuticsHundreds of M$Ubie#31Digital health › AI symptom checkerHundreds of M$MICIN#44Digital health › telemedicine and clinical trialsHundreds of M$

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.